Veradigm | MDRX - Net Income


Veradigm reported $-59.82M in Net Income for its fiscal quarter ending in December of 2022.





Net Income Change Date
Alcidion AUD 1.33M 1.21M Dec/2025
Ambu A/S DKK 118M 3M Dec/2025
Amplifon EUR 6.3M 28.94M Sep/2025
Cardinal Health USD 467M 17M Dec/2025
Centene USD -1.1B 5.53B Dec/2025
Charles River Laboratories USD -276.56M 330.98M Dec/2025
Cigna USD 1.23B 55.22B Dec/2025
Coloplast 1.4B 522M Dec/2025
Computer Programs Systems USD -9.81M 4.76M Sep/2024
Convatec Group USD 111.9M 72.6M Dec/2024
CVS Health USD 2.94B 6.92B Dec/2025
Diasorin EUR 38.26M 9.14M Sep/2025
Elevance Health USD 1.76B 1.22B Mar/2026
General Electric Aerospace USD 1.9B 637M Mar/2026
Gulf Medical Proj AED 30.2M 9.34M Dec/2025
Humana USD -796M 991M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Laboratory Of America USD 164.7M 96.4M Dec/2025
Maximus USD 75.29M 30.69M Sep/2025
McKesson USD 1.19B 76M Dec/2025
Med Life RON 7.24M 23.18M Sep/2025
Molina Healthcare USD -160M 239M Dec/2025
Omnicell USD -2.03M 7.49M Dec/2025
Oriola-kd EUR -17.9M 19.6M Dec/2025
Owens Minor USD -56.33M 93.95M Dec/2025
Quest Diagnostics USD 251M 6M Mar/2026
Rede D'or Sao Luiz BRL 1.17B 301.45M Dec/2025
Siemens Healthineers EUR 449M 139M Dec/2025
Sonova Holding CHF 188.5M 143.4M Dec/2025
Supermax Corporation Bhd MYR -58.44M 76.17M Dec/2025
UnitedHealth USD 6.28B 6.27B Mar/2026
Veeva Systems USD 244.2M 8M Dec/2025
Veradigm USD -59.82M 74.35M Dec/2022
Xerox USD -109M 19M Jun/2025